Drug Database
Back to search

Japan· JP-2129009F2034

フレカイニド酢酸塩

A flecainide product containing フレカイニド酢酸塩, registered in Japan by 寿製薬, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

On Japan’s NHI price listATC C01BC04

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedフレカイニド酢酸塩ATCC01BC04REGISTER NO.JP-2129009F2034PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about フレカイニド酢酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Flecainide is registered in 18 of 19 countries.

Countries holding a registration under ATC C01BC04 (flecainide), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 11 of them publish a price we can compare per daily dose
Search flecainide products by name

Flecainide · ATC C01BC04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of flecainide costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.49 in France to $2.20 in Switzerland — a ×4.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Flecainide · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.20
  • IT Italy$0.70
  • ES Spain$0.61
  • FR France$0.49
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
フレカイニド酢酸塩
Manufacturer
寿製薬
Country
Japan (JP)
ATC code
C01BC04
ATC class
Flecainide
Defined daily dose
0.2 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

342 interactions on record for flecainide.

Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check flecainide against other medicinesHow interaction checks work

Flecainide · interactions on record

342 records

  • 42 severe
  • 164 moderate
  • 15 minor
  • 75 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • EliglustatA16AX10severe

46 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under C01BC04

Flecainide, as other registers publish it.

All flecainide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed3fefac-52c1-4e87-a178-802329ce0f05
GET /v1/drugs/ed3fefac-52c1-4e87-a178-802329ce0f05?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１００ｍｇ１錠",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2129009F2034",
  "category": "内用薬",
  "price_yen": 20.2,
  "generic_name": "フレカイニド酢酸塩",
  "product_name_jp": null,
  "therapeutic_class": "2129",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about flecainide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console